Alterations or dysregulation of the EGF gene or its signaling pathway can be associated with various diseases, including cancers viz. colorectal cancer, non-small cell lung cancer (NSCLC), prostate and pancreatic cancers. This evidence concerns the gene EGF and colorectal cancer.